Cancer feature: cnaBRCA5

ACBD7 ADARB2 AKR1C1 AKR1C2 AKR1C3 AKR1C4 AKR1CL1 AKR1E2 ANKRD16 ASB13 ATP5C1 BEND7 C10orf111 C1QL3 CACNB2 CALML3 CALML5 CAMK1D CCDC3 CDC123 CDNF CELF2 CUBN DCLRE1C DHTKD1 DIP2C ECHDC3 FAM107B FAM171A1 FAM188A FAM208B FBXO18 FRMD4A GATA3 GDI2 GTPBP4 HSPA14 IDI1 IDI2 IL15RA IL2RA ITGA8 ITIH2 ITIH5 KIN KLF6 LARP4B MCM10 MEIG1 MRC1 MRC1L1 NET1 NMT2 NSUN6 NUDT5 OLAH OPTN PFKFB3 PFKP PHYH PITRM1 PRKCQ PROSER2 PRPF18 PRR26 PTER PTPLA RBM17 RP11-295P9.3 RPP38 RSU1 SEC61A2 SEPHS1 SFMBT2 SLC39A12 ST8SIA6 STAM SUV39H2 TAF3 TMEM236 TMEM236 TRDMT1 TUBAL3 UCMA UCN3 UPF2 USP6NL VIM WDR37

Known Driver Genes: GATA3

Copy number alternation: gain

Mitoxantrone

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer